Moan J, Bech O, Peng Q, Berg K
Institutt for Kreftforskning, Det Norske Radiumhospital, Oslo.
Tidsskr Nor Laegeforen. 1998 Mar 20;118(8):1206-11.
5-aminolevulinic acid is an early intermediate product in the synthesis of heme. Some of the enzymes in the heme synthesis chain have altered activities in tumor tissue, so that application of 5-aminolevulinic acid leads to an accumulation of protoporphyrin IX in tumors. This molecule absorbs light and acts as a potent photosensitizer; tumors containing the compound can therefore be destroyed by light. 5-aminolevulinic acid based photochemotherapy is presently being employed in the treatment of thin basal cell carcinomas in many countries. The cosmetic result of this treatment is excellent. Furthermore, it is a simple and inexpensive form of treatment with curative rates comparable to those of established therapy modalities. Experimentally, a number of other malignant lesions reachable by light via optical fibers are being treated. Since protoporphyrin IX has a characteristic red fluorescence, 5-aminolevulinic acid can also be applied for diagnostic purposes.
5-氨基乙酰丙酸是血红素合成过程中的早期中间产物。血红素合成链中的一些酶在肿瘤组织中的活性发生了改变,因此应用5-氨基乙酰丙酸会导致肿瘤组织中原卟啉IX的积累。该分子吸收光线并作为一种有效的光敏剂;因此,含有该化合物的肿瘤可被光破坏。目前,许多国家正在使用基于5-氨基乙酰丙酸的光化学疗法治疗浅表性基底细胞癌。这种治疗的美容效果极佳。此外,它是一种简单且成本低廉的治疗方式,治愈率与成熟的治疗方法相当。在实验中,一些可通过光纤用光照射到的其他恶性病变也正在接受治疗。由于原卟啉IX具有特征性的红色荧光,5-氨基乙酰丙酸也可用于诊断目的。